Document is current
Any future updates will be listed below
-
Authors
Yip, Olivia
Dhaini, Suzanne
Esser, Jan
Siqeca, Flaka
Mendieta, Maria Jose
Huber, Evelyn
Zeller, Andreas
De Geest, Sabina
Deschodt, Mieke
Zúñiga, Franziska
Zullig, Leah L.
King, Heather A.
,
Urfer, Pia
Vounatsou, Penelope
Obas, Katrina
Briel, Matthias
Schwenkglenks, Matthias
Quinto, Carlos
Blozik, Eva
-
Funding
Funding for this research was provided by:
Horizon 2020 (801076, 801076, 812656)
Swisslos Fond Baselland (RRB 1599/17)
Velux Stiftung / Velux Foundation (1167)
Swiss National Science Foundation (407440_183427 / 1)
Amt für Gesundheit Kanton Basel-Landschaft / Health Department Canton Basel-Landschaft (BL 21420023)
Durham Center of Innovation to Accelerate Discovery and Practice Transformation ((CIN 13-410), (CIN 13-410))
- License Information
-
More Information
Article History
Received: 23 June 2022
Accepted: 14 October 2022
First Online: 15 November 2022
Declarations
:
: The population survey was submitted to the Ethikkommission Nordwest- und Zentralschweiz (EKNZ) in Switzerland, BASEC Nr Req-2019-00131 for ethical approval. It did not require further review, and was able to move forward. An informed consent was obtained from all study participants. Data collection for the interviews was approved by the EKNZ under Project ID: 2020–01755 and informed consent was obtained from all study participants. A clarification of responsibility was submitted to the EKNZ to conduct the mixed methods study (Project ID: Req-2021-00170), which did not require further review. The methods used in all studies were carried out in accordance with relevant guidelines and regulations.
: Not applicable.
: Unrelated to the current work, Dr. King has funding awarded to her institution from Merck, Sharp & Dohme; Dr. Zullig consults for Novartis and Pfizer; and Dr. De Geest consults for Novartis and Sanofi. All other authors declare that they have no competing interests.
